GoldBamboo.com - Knowledge is strong medicine
  

A Pilot Trial of a Home-Based Peer Support Program to Aid Recovery Post Coronary Artery Bypass Graft Surgery - Article


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:






Home remedies

 




Clinical Trial: A Pilot Trial of a Home-Based Peer Support Program to Aid Recovery Post Coronary Artery Bypass Graft Surgery

This study is not yet open for patient recruitment.
Verified by University of Toronto January 2006

Sponsors and Collaborators: University of Toronto
Kingston General Hospital
Information provided by: University of Toronto
ClinicalTrials.gov Identifier: NCT00275340

Purpose

Coronary artery bypass graft (CABG) surgery is performed more frequently on individuals who are older and sicker than in previous years. Increased patient acuity and reduced hospital length of stays leave individuals ill prepared for their recovery following discharge. Individuals experience pain, functional impairment and depressive symptoms following discharge, which persist for 8 weeks in 50% of individuals. Unrelieved pain, functional decline and depressive symptoms predispose individuals to adverse events, impaired health-related quality of life (HRQOL), and increased morbidity and mortality.

Existing supports; including printed education materials, community care resources, cardiac rehabilitation programs and nurse-initiated telephone follow-up, fail to address concerns of individuals in this early period following hospital discharge.

Despite the positive health outcomes in other patient populations, valid studies examining the impact of telephone-based peer support to men and women after hospital discharge from CABG surgery were not found. It is anticipated that a home-based peer support program, delivered by telephone, will improve recovery and enhance HRQOL for individuals in the early weeks post hospital discharge from CABG surgery.

Condition Intervention Phase
Coronary Artery Disease
 Procedure: Peer Support
Phase I

MedlinePlus related topics:  Coronary Disease

Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Active Control, Single Group Assignment, Safety/Efficacy Study

Further study details as provided by University of Toronto:
Primary Outcomes: Health-related quality of life (SF-36v2-acute form)
Secondary Outcomes: * Pain (McGill Pain Questionnaire-Short Form); * Interference with Activities (Brief Pain Inventory-Interference Subscale); * Function (Human Activity Profile); * Depressive Symptoms (Center for Epidemiologic Studies Depression Scale)
Expected Total Enrollment:  100

Study start: February 2006;  Expected completion: November 2006
Last follow-up: September 2006;  Data entry closure: October 2006

Coronary artery bypass graft (CABG) surgery is performed more frequently on individuals who are older and sicker than in previous years. This, combined with reduced hospital length of stays, leaves individuals ill prepared for their recovery after discharge. Individuals experience pain, functional impairment and depressive symptoms; which predispose them to adverse events and impaired health-related quality of life (HRQOL). A home-based peer support program may improve recovery outcomes for individuals following CABG surgery.

The purpose of this pilot trial is to test all procedures for an adequately powered randomized controlled trial (RCT). An 8-week pre-post test RCT design with stratification for sex will enrol individuals undergoing CABG surgery at a single site in Southeastern Ontario. Participants (N=100) will include men and women, who are having first time non-emergency CABG surgery and are judged ready for discharge to home. Participants will be randomized to either a usual care (n=50) or an intervention group (usual care plus peer support)(n=50). Participants randomly assigned to the intervention group will receive individualized education and support via telephone, throughout the 8-week recovery period, by peers who possess knowledge derived from the shared experience of having CABG surgery.

A research assistant, blinded to group allocation, will collect outcome data 9-weeks following discharge. The primary endpoint for the trial is HRQOL [SF-36v2 (acute form)]. Secondary outcomes include pain [McGill Pain Questionnaire-Short Form (MPQ-SF)], and related interference with activities [Brief Pain Inventory-Interference Subscale (BPI-I)]. The Human Activity Profile (HAP) will be used to measure function and the Center for Epidemiologic Studies Depression Scale (CES-D) will be used to measure depressive symptoms.

Data analyses will include descriptive statistics. The variance and distributional properties of all outcomes will be estimated in order to inform the sample size and methods of analysis for the larger trial. To identify possible factors that form stratification factors in the larger trial, treatment effects will be compared by subgroups. Exploratory analyses will be conducted to determine an optimal analysis approach for the larger trial.

Eligibility

Genders Eligible for Study:  Both
Criteria

Inclusion Criteria (patients): Men and women who

  • are having first-time non-emergency CABG surgery
  • are judged ready for discharge
  • are being discharged to home [either their own or to family/friends]
  • have access to and are able to communicate over a telephone
  • are able to read, write and understand English

Inclusion Criteria (peers): Men and women who

  • have undergone CABG surgery within the last 5 years
  • have access to and are able to communicate clearly over a telephone
  • are able to read, write and understand English
  • have attended a formal cardiac rehabilitation program
  • are not associated with the current in-hospital peer volunteer program

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00275340

Monica J. Parry, PhD (C)      613-634-0636    parrym@kgh.kari.net
Judy Watt-Watson, PhD      416-978-2850    j.watt.watson@utoronto.ca

Canada, Ontario
      University of Toronto, Toronto,  Ontario,  M5T 1P8,  Canada
Judy Watt-Watson, PhD  416-978-2850    j.watt.watson@utoronto.ca 
Monica J. Parry, PhD (C),  Principal Investigator

Study chairs or principal investigators

Monica J. Parry, PhD (C),  Principal Investigator,  Faculty of Nursing, University of Toronto   

More Information

Study ID Numbers:  15880
Last Updated:  January 10, 2006
Record first received:  January 10, 2006
ClinicalTrials.gov Identifier:  NCT00275340
Health Authority: Canada: Ethics Review Committee
ClinicalTrials.gov processed this record on 2006-01-17


[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Home remedies.

November 24, 2009



Page Updated: January 17, 2009
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.